Please login to the form below
Fycompa
This page shows the latest Fycompa news and features for those working in and with pharma, biotech and healthcare.
Germany planning to table pricing reforms 'by the summer'
Eisai did likewise for its epilepsy treatment Fycompa (perampanel).
Latest news
-
Eisai establishes neuroscience unit in Belgium and Luxembourg
The new unit will market the company's epilepsy drug Fycompa (perampanel), which it has been giving a rolling launch across the region. ... Fycompa indicated for the adjunctive treatment of partial onset seizures, with or without secondarily generalised
-
Eisai opens first office in Australia
Eisai opens first office in Australia. New Melbourne base to support marketing of Halaven and Fycompa. ... Fycompa is the first in a new class of treatment for partial onset seizures, the most common form of epilepsy.
-
Eisai "speechless" as G-BA denies price premium for Fycompa
Eisai "speechless" as G-BA denies price premium for Fycompa. But company has better news on cancer drug Halaven. ... Eisai's efforts to secure favourable pricing for its epilepsy drug Fycompa in Germany have hit the buffers once again.
-
Eisai backs competition to find star of epilepsy comic book
Epilepsy is a relative new area of focus for Eisai, whose treatment options include Fycompa (perampanel), which was launched in Europe in 2012.
-
Eisai ‘outraged’ by IQWIG’s failure to back epilepsy drug
Eisai has issued a damning statement criticising Germany's healthcare watchdog IQWIG for not backing epilepsy drug Fycompa. ... IQWIG's recommendation will now be considered by the G-BA, which is expected to published a decision on Fycompa's use in
More from news
Approximately 13 fully matching, plus 11 partially matching documents found.
Latest Intelligence
-
Eisai: Bucking the trend with R&D growth
by adding a new solid dose global manufacturing line for its anti-epileptic medicine Fycompa. ... Fycompa was the first Eisai-developed epilepsy drug and it's “ a drug we can really differentiate”, says Hendler.
More from intelligence
Approximately 0 fully matching, plus 1 partially matching documents found.
Featured jobs
-
Senior Medical Writer
-
Great salary and benefits
- Senior Account Manager / Account Director
-
Great salary and bebefits
- Editor > Senior Editor – Medical Education – London
-
Very competitive with excellent benefits
- FREELANCE Account Manager – Creative Healthcare Advertising – Lo...
-
SUPERB DAY RATES AVAILABLE
-
Account Manager, Healthcare PR
-
£40, 000 – £42, 000 great benefits and bonuses
- Head of Operations/ BUD, Healthcare PR, London – Excellent leade...
-
Excellent Package
- Account Manager – Med Comms – London
-
Salary TBC
- Senior Medical Writer, Medical Communications, Relocate to Cardi...
-
Excellent Salary
- Senior / Principal Regulatory Writer – Home Working - UK or US
-
HIGHLEY COMPETATIVE SALARY, BONUS &BENEFITS
-
Senior Medical Writer
-
Great salary and bebefits
- FREELANCE OPPORTUNITIES!!!!! Medical Education - Healthcare Adve...
-
EXCELLENT DAY RATES AVAILABLE
- Editorial Team Leader or Scientific Director
-
£50, 000 - £55, 000 benefits
-
Scientific Director
-
Great salary and bebefits
- Senior Account Manager – Med Comms – Kent
-
Salary TBC
- Principal Medical Writer, Medical Communications, Relocate to Ca...
-
Excellent Salary
-
Senior Programme Executive
-
Salary TBC
Subscribe to our email news alerts
PMHub
Virgo Health
Virgo Health is an award-winning global healthcare communications and medical education agency comprising specialists with some of the best skills,...
Latest intelligence
- Pharma’s isolated islands of innovation
- With service design and technology often failing the patient, why perspective on improving outcomes need to change...
- Uncertainty, austerity and Brexit
- What does it mean for the life science sector?...
- The Holy Grail of HCP Access
- This is the data you need to gain access....
Quick links
Infographics
